• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脆性 X 智力低下蛋白在肝内胆管癌中的作用:调节肿瘤细胞前沿的行为可塑性。

Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge.

机构信息

Research Unit of Microscopic and Ultrastructural Anatomy, Department of Medicine, Campus Bio-Medico University, Rome, Italy.

Predictive Molecular Diagnostic Unit, Department of Pathology, Campus Bio-Medico University Hospital, Rome, Italy.

出版信息

Oncogene. 2021 Jun;40(23):4033-4049. doi: 10.1038/s41388-021-01824-3. Epub 2021 May 20.

DOI:10.1038/s41388-021-01824-3
PMID:34017076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8195741/
Abstract

Intrahepatic cholangiocarcinoma (iCCA) is a rare malignancy of the intrahepatic biliary tract with a very poor prognosis. Although some clinicopathological parameters can be prognostic factors for iCCA, the molecular prognostic markers and potential mechanisms of iCCA have not been well investigated. Here, we report that the Fragile X mental retardation protein (FMRP), a RNA binding protein functionally absent in patients with the Fragile X syndrome (FXS) and also involved in several types of cancers, is overexpressed in human iCCA and its expression is significantly increased in iCCA metastatic tissues. The silencing of FMRP in metastatic iCCA cell lines affects cell migration and invasion, suggesting a role of FMRP in iCCA progression. Moreover, we show evidence that FMRP is localized at the invasive front of human iCCA neoplastic nests and in pseudopodia and invadopodia protrusions of migrating and invading iCCA cancer cells. Here FMRP binds several mRNAs encoding key proteins involved in the formation and/or function of these protrusions. In particular, we find that FMRP binds to and regulates the expression of Cortactin, a critical regulator of invadopodia formation. Altogether, our findings suggest that FMRP could promote cell invasiveness modulating membrane plasticity and invadopodia formation at the leading edges of invading iCCA cells.

摘要

肝内胆管癌(iCCA)是一种罕见的肝内胆管恶性肿瘤,预后极差。虽然一些临床病理参数可以作为 iCCA 的预后因素,但 iCCA 的分子预后标志物和潜在机制尚未得到充分研究。在这里,我们报告脆性 X 智力低下蛋白(FMRP)在脆性 X 综合征(FXS)患者中功能性缺失的 RNA 结合蛋白,也参与多种类型的癌症,在人类 iCCA 中过度表达,并且在 iCCA 转移组织中的表达显著增加。在转移性 iCCA 细胞系中沉默 FMRP 会影响细胞迁移和侵袭,提示 FMRP 在 iCCA 进展中起作用。此外,我们还证明 FMRP 定位于人类 iCCA 肿瘤巢的侵袭前沿以及迁移和侵袭的 iCCA 癌细胞的伪足和侵袭伪足突起中。在这里,FMRP 结合编码这些突起形成和/或功能的关键蛋白的几种 mRNA。特别是,我们发现 FMRP 结合并调节 Cortactin 的表达,Cortactin 是侵袭伪足形成的关键调节剂。总之,我们的研究结果表明,FMRP 可以通过调节细胞膜的可塑性和侵袭性 iCCA 细胞前缘的侵袭伪足形成来促进细胞侵袭性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/f53a3024340b/41388_2021_1824_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/bcf4c0413aa1/41388_2021_1824_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/e791a0daa78c/41388_2021_1824_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/371e61b6ac6f/41388_2021_1824_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/203076557408/41388_2021_1824_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/4299ef4fa788/41388_2021_1824_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/78448df1766a/41388_2021_1824_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/cf2055790035/41388_2021_1824_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/f53a3024340b/41388_2021_1824_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/bcf4c0413aa1/41388_2021_1824_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/e791a0daa78c/41388_2021_1824_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/371e61b6ac6f/41388_2021_1824_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/203076557408/41388_2021_1824_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/4299ef4fa788/41388_2021_1824_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/78448df1766a/41388_2021_1824_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/cf2055790035/41388_2021_1824_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a3/8195741/f53a3024340b/41388_2021_1824_Fig8_HTML.jpg

相似文献

1
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge.脆性 X 智力低下蛋白在肝内胆管癌中的作用:调节肿瘤细胞前沿的行为可塑性。
Oncogene. 2021 Jun;40(23):4033-4049. doi: 10.1038/s41388-021-01824-3. Epub 2021 May 20.
2
MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.MUC13通过表皮生长因子受体/磷脂酰肌醇-3激酶/蛋白激酶B通路促进肝内胆管癌进展。
J Hepatol. 2020 Apr;72(4):761-773. doi: 10.1016/j.jhep.2019.11.021. Epub 2019 Dec 16.
3
miR-885-5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma.miR-885-5p通过靶向IGF2BP1和GALNT3抑制人肝内胆管癌的增殖和转移。
Mol Carcinog. 2020 Dec;59(12):1371-1381. doi: 10.1002/mc.23262. Epub 2020 Oct 14.
4
Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD.核仁素乳酰化通过对MADD的RNA剪接调控促进肝内胆管癌的发病机制。
J Hepatol. 2024 Oct;81(4):651-666. doi: 10.1016/j.jhep.2024.04.010. Epub 2024 Apr 27.
5
Membrane RRM2-positive cells represent a malignant population with cancer stem cell features in intrahepatic cholangiocarcinoma.膜 RRM2 阳性细胞代表肝内胆管癌中具有癌症干细胞特征的恶性群体。
J Exp Clin Cancer Res. 2024 Sep 6;43(1):255. doi: 10.1186/s13046-024-03174-w.
6
ST3GAL1 Promotes Malignant Phenotypes in Intrahepatic Cholangiocarcinoma.ST3GAL1 促进肝内胆管癌的恶性表型。
Mol Cell Proteomics. 2024 Sep;23(9):100821. doi: 10.1016/j.mcpro.2024.100821. Epub 2024 Jul 26.
7
Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma.揭示 HP1α-HDAC1-STAT1 轴作为 HP1α 阳性肝内胆管癌治疗靶点的作用。
J Exp Clin Cancer Res. 2024 May 30;43(1):152. doi: 10.1186/s13046-024-03070-3.
8
Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis.西尼莫司他,一种选择性 NOTCH1 抑制剂,通过阻断 VEGFA/DLL4/MMP13 轴减少肝内胆管癌的进展。
Cell Death Differ. 2020 Aug;27(8):2330-2343. doi: 10.1038/s41418-020-0505-4. Epub 2020 Feb 10.
9
Neurokinin-1 receptor antagonist aprepitant regulates autophagy and apoptosis via ROS/JNK in intrahepatic cholangiocarcinoma.神经激肽-1 受体拮抗剂阿瑞匹坦通过 ROS/JNK 调节肝内胆管癌中的自噬和凋亡。
Liver Int. 2024 Jul;44(7):1651-1667. doi: 10.1111/liv.15904. Epub 2024 Mar 30.
10
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma.HSF1 是肝内胆管癌的预后决定因素和治疗靶点。
J Exp Clin Cancer Res. 2024 Sep 6;43(1):253. doi: 10.1186/s13046-024-03177-7.

引用本文的文献

1
: A Neurodevelopmental Factor Regulating Cell Metabolism in the Tumor Microenvironment.一种调节肿瘤微环境中细胞代谢的神经发育因子。
Biomolecules. 2025 May 28;15(6):779. doi: 10.3390/biom15060779.
2
The role of RNA binding proteins in cancer biology: A focus on FMRP.RNA结合蛋白在癌症生物学中的作用:聚焦于脆性X智力低下蛋白(FMRP)
Genes Dis. 2024 Dec 21;12(4):101493. doi: 10.1016/j.gendis.2024.101493. eCollection 2025 Jul.
3
A Nanostring gene expression approach identifies aggressive clinical behavior related genes in dedifferentiated liposarcoma.

本文引用的文献

1
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.肝内和肝外胆管癌的危险因素:系统评价和荟萃分析。
J Hepatol. 2020 Jan;72(1):95-103. doi: 10.1016/j.jhep.2019.09.007. Epub 2019 Sep 16.
2
A Synaptic Perspective of Fragile X Syndrome and Autism Spectrum Disorders.脆性 X 综合征与自闭症谱系障碍的突触观点
Neuron. 2019 Mar 20;101(6):1070-1088. doi: 10.1016/j.neuron.2019.02.041.
3
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.肝内胆管细胞癌:持续的挑战和转化进展。
一种纳米串基因表达方法可识别去分化脂肪肉瘤中与侵袭性临床行为相关的基因。
Sci Rep. 2025 Mar 17;15(1):9204. doi: 10.1038/s41598-025-91791-6.
4
LINC01305 and LAD1 Co-Regulate CTTN and N-WASP Phosphorylation, Mediating Cytoskeletal Reorganization to Promote ESCC Metastasis.LINC01305与LAD1共同调节CTTN和N-WASP磷酸化,介导细胞骨架重组以促进食管鳞状细胞癌转移。
Mol Carcinog. 2025 Apr;64(4):756-768. doi: 10.1002/mc.23885. Epub 2025 Jan 21.
5
FMRP expression in primary breast tumor cells correlates with recurrence and specific site of metastasis.原发性乳腺癌细胞中 FMRP 的表达与复发和特定转移部位相关。
PLoS One. 2023 Jun 28;18(6):e0287062. doi: 10.1371/journal.pone.0287062. eCollection 2023.
6
M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy.m6A 修饰的 circRBM33 通过 PDHA1 介导的线粒体呼吸调节促进前列腺癌进展,并为 ARSI 治疗提供了一个潜在的靶点。
Int J Biol Sci. 2023 Mar 5;19(5):1543-1563. doi: 10.7150/ijbs.77133. eCollection 2023.
7
FMRP modulates the Wnt signalling pathway in glioblastoma.FMRP 调节神经胶质瘤中的 Wnt 信号通路。
Cell Death Dis. 2022 Aug 18;13(8):719. doi: 10.1038/s41419-022-05019-w.
8
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.胆管癌中的新分子机制:触发肿瘤细胞产生白细胞介素 6 的信号以及 KRAS 挪用的表观遗传介质驱动代谢重编程。
J Exp Clin Cancer Res. 2022 May 26;41(1):183. doi: 10.1186/s13046-022-02386-2.
9
Intercepting IRE1 kinase-FMRP signaling prevents atherosclerosis progression.阻断 IRE1 激酶-FMRP 信号通路可阻止动脉粥样硬化进展。
EMBO Mol Med. 2022 Apr 7;14(4):e15344. doi: 10.15252/emmm.202115344. Epub 2022 Feb 22.
Hepatology. 2019 Apr;69(4):1803-1815. doi: 10.1002/hep.30289. Epub 2019 Mar 25.
4
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma.组蛋白甲基转移酶 G9a 和 DNA 甲基转移酶 1 的双重靶向治疗实验性肝细胞癌。
Hepatology. 2019 Feb;69(2):587-603. doi: 10.1002/hep.30168. Epub 2019 Jan 4.
5
HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein.在各种脑区的 HITS-CLIP 揭示了脆性 X 智力迟钝蛋白通过新的靶点和新的 RNA 结合方式。
Nucleic Acids Res. 2018 Jul 6;46(12):6344-6355. doi: 10.1093/nar/gky267.
6
GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth.GKAP 作为 NMDA 信号的遗传调节剂调控侵袭性肿瘤生长。
Cancer Cell. 2018 Apr 9;33(4):736-751.e5. doi: 10.1016/j.ccell.2018.02.011. Epub 2018 Mar 29.
7
The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells.脆性 X 智力低下蛋白调节黑素瘤细胞中与肿瘤侵袭相关的通路。
Cell Death Dis. 2017 Nov 16;8(11):e3169. doi: 10.1038/cddis.2017.521.
8
Cholangiocarcinoma - evolving concepts and therapeutic strategies.胆管癌——不断演变的概念与治疗策略
Nat Rev Clin Oncol. 2018 Feb;15(2):95-111. doi: 10.1038/nrclinonc.2017.157. Epub 2017 Oct 10.
9
Absence of the Fragile X Mental Retardation Protein results in defects of RNA editing of neuronal mRNAs in mouse.缺乏脆性 X 智力迟钝蛋白导致小鼠神经元 mRNA 的 RNA 编辑缺陷。
RNA Biol. 2017 Nov 2;14(11):1580-1591. doi: 10.1080/15476286.2017.1338232. Epub 2017 Sep 5.
10
Tumor Cell Invadopodia: Invasive Protrusions that Orchestrate Metastasis.肿瘤细胞侵袭伪足:协调转移的侵袭性突起。
Trends Cell Biol. 2017 Aug;27(8):595-607. doi: 10.1016/j.tcb.2017.03.003. Epub 2017 Apr 12.